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Abstract— Gut microbiota contribute to shaping the immune repertoire of the host, 
whereas probiotics may exert beneficial effects by modulating immune responses. Having 
in mind the differences in both the composition of gut microbiota and the immune response 
between rats of Albino Oxford (AO) and Dark Agouti (DA) rat strains, we investigated if 
intraperitoneal (i.p.) injection of live Lactobacillus rhamnosus (LB) may influence peri-
toneal cavity cell response to in vitro treatments with selected microbiota in the rat strain-
dependent manner. Peritoneal cavity cells from AO and DA rats were lavaged two (d2) 
and seven days (d7) following i.p. injection with LB and tested for NO, urea, and  H2O2 
release basally, or upon in vitro stimulation with autologous E.coli and Enterococcus spp. 
Whereas the single i.p. injection of LB nearly depleted resident macrophages and increased 
the proportion of small inflammatory macrophages and monocytes on d2 in both rat strains, 
greater proportion of  MHCIIhiCD163− and  CCR7+ cells and increased NO/diminished 
 H2O2 release in DA compared with AO rats suggest a more intense inflammatory prim-
ing by LB in this rat strain. Even though E.coli- and/or Enterococcus spp.-induced rise 
in  H2O2 release in vitro was abrogated by LB in cells from both rat strains, LB prevented 
microbiota-induced increase in NO/urea ratio only in cells from AO and augmented it 
in cells from DA rats. Thus, the immunomodulatory properties may not be constant for 
particular probiotic bacteria, but shaped by innate immunity of the host.
KEY WORDS: Albino Oxford (AO) rats; Dark Agouti (DA) rats; Lactobacillus rhamnosus; Peritoneal  
cavity immune cells; E. coli; Enterococcus spp.
INTRODUCTION
Gut microbiota dysbiosis and increased gut perme-
ability are associated with increased risk for inflamma- 
tory and autoimmune diseases [1–3]. Even in the absence 
of infection, gut microbiota constituents are constantly 
turned over and either excreted or translocated across 
the gut mucosa into the circulation, which contributes 
to basal level of immune cell activation and facilitates a 
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rapid response to pathogens [4]. Resident peritoneal cav- 
ity cells that guard the sterility of the peritoneal compart-
ment against the microbial threat from the gut are in close 
contact with escaped intraluminal bacteria and support 
shaping the immune repertoire of the host [5].
We have recently reported that peritoneal cavity 
cells from rats of Dark Agouti (DA) rat strain displayed 
more vigorous priming and inflammatory response upon 
intraperitoneal (i.p.) stimulation with own commensal 
E.coli and Enterococcus spp., compared to the cells from 
rats of Albino Oxford (AO) rat strain [6]. These non-MHC 
compatible rat strains substantially differ in their suscep-
tibility to the induction of autoimmune diseases, DA 
rats being significantly more susceptible to experimental 
autoimmune encephalomyelitis and adjuvant arthritis [7, 
8]. There is higher variability of Lactobacillus spp. in 
AO rats, in both faecal and gut tissue samples [9], while 
DA rat samples contain other bacteria, like those from 
phylum Firmicutes (including family Lachnospiraceae) 
and phylum Proteobacteria (including Undibacterium 
oligocarboniphilum from order Burkholderiales) [10]. 
Transfer of AO gut microbiota even ameliorated EAE in 
DA rats [11], underlining the importance of commensal 
microbial constituents for host immune response. Since 
microbiota drives the differentiation of infiltrating mono-
cytes to  MHCII+ resident peritoneal cavity macrophages 
[12], the differences in the composition of commensal 
microbiota between AO and DA rats probably contribute 
to differences between these rat strains in the response of 
macrophages to peritoneal cavity micro-environmental 
changes in vivo and treatments in vitro [13–16].
On the other hand, the use of probiotic bacteria 
with the intent to improve gut dysbiosis was shown to 
exert beneficial effects not only toward inflammatory 
bowel diseases, but also in blunting the signs of inflam-
matory and autoimmune diseases [17, 18]. Probiotics 
exercise complex activities beyond the gastrointestinal 
tract, including bacterial strain-specific immunomodu- 
latory properties, and the diverse genus Lactobacillus 
stands out as particularly useful and safe. Oral gavage 
with lactobacilli may increase or decrease peritoneal 
cell phagocytic activity and IL-6, IL-12, and IFN-γ pro-
duction, depending on particular Lactobacillus strain 
used [19, 20]. However, lactobacilli also express immu-
nomodulatory properties following i.p. route of delivery 
by stimulating macrophage phagocytosis [21], MHCII 
expression [22] and lysosomal activity [23]. I.p. injection 
of lactobacilli eventually resulted in antimicrobial and 
disease-changing effects in both local and distant sites, 
i.e., inhibited growth of Pseudomonas aeruginosa in the 
peritoneal cavity [24], diminished Trichinella spiralis lar- 
vae burden in the intestine [25], and conveyed protection 
against Listeria monocytogenes or Babesia microti infec-
tion [26, 27]. Single i.p. injection of Lactobacillus spp. 
even mimicked the beneficial effect(s) of oral consump- 
tion of Lactobacillus spp. on inflammatory score during 
experimental colitis [28].
Hence, we wanted to extend our previous observa- 
tions in AO and DA rat strains by modifying peritoneal 
cavity cells of these rats with a direct i.p. stimulation 
with Lactobacillus rhamnosus (LB) prior to treatment 
with selected microbiota in vitro. This particular probi-
otic strain possesses immunomodulatory properties, as 
it increases IFN-γ /IL-4 ratio in lymph node cells when 
used as adjuvant for ocular mucosal immunization in 
mouse [29]. It also improves the health of adult rats with 
colitis when applied during early postnatal period, most 
probably by increasing microbiota diversity and intestinal 
growth during early life [30]. Given that variations in the 
efficacy of probiotics may be a result of inter-individual 
differences in probiotic colonization [31] and that data 
regarding the efficacy of probiotics as a result of dif- 
ferences in host innate immunity are lacking, we were 
interested to investigate whether i.p. LB may affect peri-
toneal cavity cells and bias their response to subsequent 
microbial stimuli in a rat strain-dependent way. In the 
present study, we employed i.p. stimulation with LB in 
order to explore direct effect on phenotype and activity 
of cells in situ, and to circumvent changes in microbial 
composition and metabolic conditions or influence on 
other immune cells [32], which all accompanies the oral 
feeding with lactobacilli. For that purpose, peritoneal cav- 
ity cells from AO and DA rats were lavaged 2 and 7 days 
following i.p. injection of LB and then stimulated with 
autologous E.coli and Enterococcus spp. in vitro.
MATERIALS AND METHODS
Animals
Young (4–6-month-old) female rats of Albino 
Oxford (AO) and Dark Agouti (DA) rat strains were 
obtained from the local breeding colony (Immunology 
Research Center “Branislav Janković,” Belgrade, Serbia). 
Rats were housed in a strain-matched manner in standard 
cages (3 rats/cage) in an environment in which tempera- 
ture (22 ± 2 °C), humidity (40% to 70%), and light/dark 
Lactobacillus rhamnosus Affects Rat Peritoneal Cavity Cell Response to Stimulation with…
cycle (12:12 h) were automatically controlled. The rats 
had free access to conventional food pellets (Veterinar- 
ski zavod Subotica, Serbia) and tap water. Animals were 
euthanized by increasing dose of  CO2.
The experimental protocol and the procedures 
involving animals and their care were approved by 
Ministry of Agriculture and Environmental Protection 
(licence number 323–07-01,577/2016–05/14, issued on 
02–25-2016), and were in accordance with the princi-
ples declared in Directive 2010/63/EU of the European 
Parliament and of the Council from 22 September 2010 
on the protection of animals used for scientific purposes 
(revising Directive 86/609/EEC).
Isolation and Preparation of Bacteria
Lactobacillus rhamnosus (LB) was generously 
provided by Dr Vesna Cvetković, Institute of Virology, 
Vaccines and Sera “Torlak” (Belgrade, Serbia). LB was 
isolated from human gastrointestinal flora at Institute of 
Virology, Vaccines and Sera “Torlak,” and has been char-
acterized by 16S rRNA gene sequencing and subsequent 
sequence analysis (NCIMB Ltd, Aberdeen, UK; assigned 
strain name NCSQ 18,723), showing a sequence simi- 
larity of 99.41% when compared with the Lactobacillus 
rhamnosus species.
Commensal bacteria were isolated from stool speci-
mens collected from AO and DA rats, and prepared as 
previously described [33]. Briefly, faecal samples were 
cultured using different agar plates (MacConcey agar 
medium, Endo agar medium, Institute “Torlak,” Bel-
grade, Serbia) under the aerobic conditions, at 37 °C for 
24 h and well-isolated colonies were identified using the 
Gram-staining and morphological characteristics, as well 
as the biochemical tests and a rapid identification system 
(ID-32A, API Biomerieux, Marcy l’Etoile, France). The 
Bile Esculin Agar medium (Institute “Torlak”) was used 
for confirmation of the Enterococcus genus. Further iden-
tification of the species of enterococci was not obtained 
(MALDI-TOF analysis failed to provide identification 
using VITEK® MS V2.0 Knowledge Base, Biomerieux).
E. coli and Enterococcus spp., identified as aerobic 
Gram ( −) and Gram ( +) bacteria, respectively, in both 
AO and DA rats, were grown aerobically for 24 h, har-
vested at stationary growth phase, washed with sterile 
phosphate-buffered saline (PBS) (1000 × g for 20 min), 
and resuspended in sterile PBS. The bacteria were killed 
by formalin (at 0.5% v/v final concentration), and the 
suspensions were held at 35 °C for more than 48 h. Cells 
were then washed with PBS to remove the formaldehyde, 
resuspended at the same density in sterile PBS/0.25% 
phenol and stored at 4 °C until use. The efficacy of kill-
ing of the bacteria in the suspensions was confirmed by 
sterility test. The estimated number of bacteria in the sus-
pension was determined by reading the optical density 
at 580 nm and extrapolating the value using a standard 
curve.
Chemicals and Immunoconjugates
Lipopolysaccharide (LPS), phorbol 12-myristate 
13-acetate (PMA), phenylmethyl sulfonyl fluoride 
(PMSF), phenol red, α-isonitrosopropiophenone (ISPF), 
o-phenylene diamine (OPD), and RPMI-1640 medium 
(RPMI) were purchased from Sigma (St. Lewis, MO, 
USA). Foetal calf serum (FCS) was obtained from Gibco 
(Grand Island, NY, USA).
Monoclonal PE-conjugated mouse anti-rat CD163 
(ED2-like) resident macrophage receptor (clone HIS 
36), FITC-conjugated goat anti-rabbit IgG (GAR-FITC), 
FITC-conjugated goat anti-mouse (GAM-FITC), FITC-
conjugated mouse anti-rat MHCII, alexa-fluor 488- 
conjugated mouse anti-rat Ki67, PerCP-conjugated streptavidin 
(Sav-PerCP), and appropriate IgG isotype controls were 
purchased from BD Biosciences Pharmingen (Moun- 
tain View, CA, USA). Biotin-conjugated mouse anti-rat 
CD68 (clone ED1) antibodies were obtained from Serotec 
(Oxford, UK). Polyclonal rabbit anti-rat C–C chemokine 
receptor type 7 (CCR7) antibody was obtained from 
Abcam (Cambridge, MA, USA); PE-conjugated mouse 
anti-rat granulocyte antibodies (clone HIS48) were pur-
chased from eBioscience (San Diego, CA, USA). PE- 
conjugated mouse anti-rat CD43 (clone W3/13) was pur-
chased from BioLegend (San Diego, CA, USA).
Intraperitoneal Treatment with Lactobacillus 
rhamnosus and General health Monitoring
AO and DA rats were treated with a single i.p. injec-
tion containing ~ 5 ×  107 CFU LB in 300 µl of PBS, and 
peritoneal cavity cells were sampled by lavage 2 days (d2 
LB) or 7 days (d7 LB) later. Pereyra and colleagues estab-
lished that 5 ×  107 of live lactobacilli was the maximal 
non-lethal quantity of injected bacteria [34].
Control rats were treated with a single i.p. injec-
tion of 300 µl of PBS, and peritoneal cells were isolated 
2 days later. Preliminary experiments showed that the 
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number, phenotype, and functional activity were similar 
in peritoneal cells isolated either 2 or 7 days following 
i.p. injection of PBS.
Clinical appearance of rats challenged with live 
LB was monitored daily for 7 days. Subjective aspects of 
behaviour were recorded according to the General Health 
Score scale [35] ranged from S5 (bright eyed and alert, 
a smooth coat with a sheen, responds to stimulus, shows 
interest in environment) to S1 (nonreactive to stimulus, 
fur has a “bottle brush” appearance, hunched over pre-
ferring to sleep than react to environment, cold at touch, 
paws cold). Rats were weighed at the beginning of the 
experiment, and on days 2 and 7 following LB injection.
Isolation of Peritoneal Cavity Cells
Prior to peritoneal lavage, abdominal skin with fur 
was soaked with 70% alcohol and retracted to expose the 
intact peritoneal wall. Small incision was made along the 
midline with sterile scissors. A total of 10 ml of sterile 
ice-cold PBS pH 7.4 supplemented with 2% foetal calf 
serum (FCS) was injected and entire body gently shaked 
for 10 s by use of forceps. After exposing the peritoneal 
cavity, the fluid was gently aspirated. Individual cell sus-
pensions were washed twice in PBS/2%FCS (250 × g) at 
4 °C and subjected to flow cytometry analysis and func-
tional tests.
Flow Cytometric Analysis of Peritoneal Cavity 
Cells
Flow cytometric analysis of peritoneal cavity cells 
was performed immediately following their isolation. 
Individual cell aliquots (50 μl, 1 ×  107 cells/ml) were 
immunolabeled and then analysed on a FACSVerse™ 
flow cytometer using BD FACSuite™ software (Becton 
Dickinson, Mountain View, CA, USA). Debris and dead 
cells were gated out on the basis of low FSC and low 
SSC. Cell doublets were excluded by displaying the FSC 
height values over the FSC area values.
For surface staining, peritoneal cells were immu-
nolabeled with FITC-conjugated anti-MHCII and PE-
conjugated anti-CD163, or with biotin-conjugated 
HIS48, and PE-conjugated anti-CD43 antibodies. For 
secondary staining, the latter cells were incubated (after 
washing in PBS/NaN3/2%FCS) with PerCP-conjugated 
streptavidin. The MHCII-FITC vs CD163-PE plot 
was used for identifying four relevant cell populations: 
 CD163+MHCII−,  CD163+MHCII+,  CD163−MHCIIlow, 
and  CD163−MHCIIhigh. CD43-PE vs HIS48-SavPerCP 
revealed that  HIS48+CD43+ cells may be clearly distin-
guished by SSC (monocytes are  SSClow, and granulocytes 
are  SSChigh).
For intracellular staining, peritoneal cells were 
first labelled with unconjugated rabbit anti-CCR7 and 
PE-conjugated anti-CD163, and after washing, with 
FITC-conjugated anti-rabbit IgG. Cells were then 
fixed with 0.25% paraformaldehyde and permeabilized 
by 0.2% Tween 20, prior to the addition of biotin- 
conjugated anti-CD68. Anti-CD163 antibody labels the 
mature tissue resident macrophages, but not monocytes 
[36]. CD68 antigen is considered as pan-macrophage 
marker, but it labels dendritic cells as well [37]. All 
 CD163+ cells expressed CD68. For intracellular Ki67 
staining, cells were first labelled with PE-conjugated 
anti-CD43, then fixed and permeabilized using the Fix-
Perm buffer (otherwise used for Foxp3 staining, eBio-
science, San Diego, CA, USA) after which the cells 
were labelled with alexa-fluor 488-conjugated anti-Ki67 
and biotin-conjugated anti-CD68, followed by Sav-
PerCP-conjugated streptavidin.
Functional Tests
Individual cell aliquots were adjusted to 1 ×  106 
cells/ml (for nitric oxide, urea, and cytokine produc-
tion) or to 2.5 ×  106 cells/ml (for hydrogen peroxide pro-
duction) in RPMI/5%FCS. Cell aliquots were plated to 
tissue culture plates for 2 h at 37 °C/5%  CO2. The non-
adherent cells were removed by warm sterile PBS, and 
adherent cells (highly enriched for macrophages) [38] 
were additionally incubated for 1 h (hydrogen peroxide 
production), 24 h (cytokine release), or for 48 h (nitric 
oxide and urea production). Optical densities (OD) were 
determined by Multiscan Ascent plate reader (Labsys-
tems, Helsinki, Finland).
Hydrogen Peroxide (H2O2) Release Assay.  H2O2 
release was determined according to a method based on 
the HRPO-dependent oxidation of phenol red [39, 40]. 
Briefly, adherent cells were primed for peroxide produc-
tion for 1 h at 37 °C with 100 µl of 25 nM PMA in phenol 
red solution (10 mM potassium phosphate buffer pH 7, 
140 mM NaCl, 5.5 mM dextrose, 0.56 mM phenol red, 
and 19 U/ml of HRPO), in the absence or in the presence 
of 100 µl of 3 ×  108 CFU/ml of E.coli or 3 ×  108 CFU/
ml of Enterococcus spp. Incubations were terminated 
with 10 µl of 0.5 M NaOH, and ODs were determined 
at 620 nm. The concentration of  H2O2 in the samples 
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was calculated using standard concentrations of  H2O2 
(1–100 µM).
Cytokine Determination. Adherent cells were incu-
bated for 24 h at 37 °C/5%  CO2 in RPMI/5%FCS, and 
culture supernatants were frozen at − 70 °C until assayed. 
Prior to performing ELISA, the thawed supernatants were 
centrifuged on 250 g, 15 min, + 4  °C. Commercially 
available ELISA kits for tumour necrosis factor (TNF)-α 
(Biolegend Inc., San Diego, CA, USA) and interleukin 
(IL)-10 (R&D Systems Inc., Minneapolis, MN, USA) 
were used according to the manufacturers’ instructions.
Nitric Oxide (NO) and Urea Determination Assays. 
Adherent cells were incubated for 48 h at 37 °C/5%  CO2 
in 100 µl of RPMI/5%FCS, in the absence or in the pres-
ence of 1 µg/ml LPS, or 3 ×  108 CFU/ml of E.coli or 
3 ×  108 CFU/ml Enterococcus spp. Supernatants were 
collected and immediately analysed for nitrite concentra-
tion by a method based on the Griess reaction [41]. The 
concentration of nitrite in the samples was determined 
according to ODs measured at 405 nm and calculated 
using a  NaNO2 (1–40 μM) as a standard.
The plates were then centrifuged for 5 min at 100 g 
and rinsed with warm PBS. Cells were lysed with 0.1% 
Triton X-100 containing 2 mM PMSF and shaked for 
30 min (200 cycles/minute). Enzyme arginase was acti-
vated by 10 mM  MnCl2/25 mM Tris–HCl, pH 7.5, for 
10 min at 56 °C and 0.5 M arginine; pH 9.7 was added for 
next 22 h incubation at 37 °C. The reaction was stopped 
by acid mixture containing  H2SO4,  H3PO4, and  H2O 
(1:3:7). Arginase activity was indirectly determined by 
measuring the metabolite urea [42, 43]. The urea con-
centration was measured at 540 nm after adding ISPF 
dissolved in absolute ethanol, followed by heating at 
95 °C for 45 min and calculated according to the stand-
ard curve obtained with known concentrations of a urea 
(25–1600 µM).
Statistical Analysis
GraphPad Prism 5 (GraphPad Software, San Diego, 
CA) was used for all calculations and statistical analysis. 
Statistical significance level was set at p < 0.05. Since 
the experimental design included variations in several 
factors, data were analysed by two-way ANOVA with 
factors rat strain (AO vs. DA) and treatment (PBS, d2 
LB, and d7 LB). The effects of in vitro treatment with 
E.coli or Enterococcus spp. were analysed by one-way 
ANOVA. Bonferroni’s multiple comparison post hoc test 
was performed.
RESULTS
The Health Concerns, Body Weight, 
the Number of Peritoneal Cavity Cells, 
and the Proportion of  CD163+CCR7+ Cells 
Following Intraperitoneal Injection of LB
We did not record any deaths or discomfort of ani-
mals during this study. Bright eyed rats with a smooth coat 
and vigorous response to environmental stimuli during 
7-day period after LB injection confirmed score 5 accord-
ing to the General Health Score scale [35]. Moreover, sin-
gle i.p. injection of 5 ×  107 CFU of live LB did not affect 
body weight of any rat over the course of experiment 
(Fig. 1A) but increased the number of peritoneal cavity 
cells in both AO and DA rats, relative to strain-matched 
PBS-treated animals (Fig. 1B). Injection of LB substan-
tially increased peritoneal cell number in AO rats only on 
d2 following injection, whereas it augmented cell number 
on both d2 and d7 after injection in DA rats (Fig. 1B). It 
is noteworthy that the number of peritoneal cavity cells 
obtained on d2 was significantly higher in AO relative to 
DA rats, while on d7 the number of peritoneal cells was 
slightly higher in DA relative to AO rats (Fig. 1B).
In accordance with our previous reports, the major-
ity of peritoneal cavity cells and all  CD163+ macrophages 
expressed CD68, irrespective of rat strain and treatment 
(data not shown).
The proportion of all  CD163+ macrophages among 
peritoneal cavity cells was significantly higher in AO than 
in DA rats treated with PBS or on d7 following LB, but 
comparable between AO and DA rats on d2 (Fig. 1C). 
Even though  CD163+ macrophages of both rat strains 
expressed CCR7 antigen (Fig. 1C), only minute fraction 
of  CD163+ macrophages of AO rats treated with PBS 
and those treated with LB seven days before cell har-
vest expressed CCR7. Quite the opposite, in PBS-treated 
DA rats at least half of  CD163+ macrophages expressed 
CCR7 (Fig.  1C). It is worth noting that in samples 
obtained from both rat strains on d2, and in cells from DA 
rats on d7 following LB treatment, all peritoneal  CD163+ 
cells expressed CCR7 (Fig. 1C).
Phenotype of Peritoneal Cavity Cells Induced 
by Intraperitoneal Injection of LB
LB injection abruptly reduced the proportion of 
 CD68+ macrophages that express proliferative Ki67 
marker on d2, which remained slightly diminished on d7 
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when compared to cells from PBS-treated animals in both 
strains (Fig. 2B). Nevertheless, the ratio of  CD68+Ki67+ 
cells was lower among peritoneal cavity cells from DA 
compared to AO rats, irrespective of treatment (Fig. 2B).
Treatment with LB diminished the proportion of 
classical  (CD163+MHCII−) large resident macrophages in 
d2 samples and increased the proportion of small inflam-
matory  MHCIIlow-expressing  CD163− macrophages 
(Fig. 3B) in AO rats. LB did not affect the proportion of 
other resident macrophage  (CD163+MHCII+) and inflam-
matory macrophage/dendritic cell  (CD163−MHCIIhi) 
populations in these rats on d2 (Fig. 3B). In peritoneal 
cavity cells obtained on d7 following LB injection in AO 
rats, there was an increase in the proportion of resident 
(both  MHCII− and  MHCII+)CD163+ and inflammatory 
 CD163−MHCIIlow macrophages (Fig. 3B). In DA rats, treat-
ment with LB diminished ratio of resident macrophages 
 (CD163+MHCII− and  CD163+MHCII+) and increased 
Fig. 1  Body weight (A), the number of peritoneal cells (B), and the 
proportion of  CD163+CCR7+ and  CD163+CCR7− cells (C) in rats 
of Albino Oxford (AO) and Dark Agouti (DA) rat strains following 
intraperitoneal treatment with phosphate buffer saline (PBS), or two 
(d2) and seven (d7) days following intraperitoneal treatment with Lac-
tobacillus rhamnosus (LB). The number of rats was 3–6 per group. 
Statistically significant differences: #p < 0.05 and ##p < 0.01 vs. PBS; 
ap < 0.05, bp < 0.01, and cp < 0.001 vs. AO rats. Statistically significant 
differences in (C) refers to  CD163+ (including  CCR7+ and  CCR7−) 
cells.
◂
Fig. 2  Representative dot plots showing the Ki67 vs. CD68 immunofluorescence profile (A) and the proportion of  Ki67+CD68+ cells (B) in rats of 
Albino Oxford (AO) and Dark Agouti (DA) rat strains following PBS, or two (d2) and seven (d7) days following intraperitoneal treatment with Lac-
tobacillus rhamnosus (LB). The number of rats was 3–6 per group. Statistically significant differences: #p < 0.05 and ##p < 0.01 vs. PBS; ap < 0.05, 
bp < 0.01, and cp < 0.001 vs. AO rats.
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the proportion of small inflammatory  (CD163−MHCIIlow) 
macrophages, and inflammatory macrophage/dendritic 
cells  (CD163−MHCIIhi) on d2 (Fig. 3B). However, on d7, 
the proportion of both resident  CD163+MHCII+ and small 
inflammatory  (CD163−MHCIIlow) macrophages was dimin-
ished in comparison with PBS-treated DA rats (Fig. 3B). 
Rat strain differences were observed among PBS-treated 
rats, as greater proportion of  CD163+MHCII+ and, espe-
cially, of  CD163−MHCIIlow cells, accompanied with dimin-
ished ratio of  CD163+MHCII− cells in DA compared to 
AO rats was noticed. Following LB injection, the propor-
tion of  CD163−MHCIIhi cells was greater on d2 in DA rats, 
whereas the proportion of resident  CD163+ macrophages 
(both  MHCII−and  MHCII+) was greater on d7 in AO rats 
(Fig. 3B).
Treatment with LB in both rat strains significantly 
enriched peritoneal cavity cell population by influx of 
 SSClow (less granular)  HIS48+CD43+ monocytes on d2 
(Fig. 4B, left), which accompanied decrease in the propor-
tion of mature resident CD163-expressing macrophages 
(Fig.  1C). The proportion of  SSClow  HIS48+CD43+ 
monocytes was higher in AO relative to DA rats (Fig. 4B, 
left). In further course of inflammation, decrease in the 
proportion of  SSClow  HIS48+CD43+ monocytes on d7 
was accompanied by the recovery of resident  CD163+ 
peritoneal macrophages in both rat strains (Fig. 1C). The 
ratio of peritoneal granulocytes  (SSChi  HIS48+CD43+ 
cells) did not change following LB injection in either of 
rat strains (Fig. 4B, right).
Release of Hydrogen Peroxide  (H2O2), 
Cytokines, Nitric Oxide and Urea 
from Adherent Peritoneal Cavity Cells 
Following Intraperitoneal Injection of LB
In AO rats, single i.p. LB injection increased 
 H2O2 release from peritoneal cells isolated on d2 and d7 
(Fig. 5A) relative to cells from PBS-treated rats. How-
ever, in DA rats, LB injection decreased  H2O2 release 
from cells isolated on d2, but increased it in those isolated 
on d7 (Fig. 5A). Adherent peritoneal cells from PBS-
treated rats of AO and DA strain produced comparable 
quantity of  H2O2, whereas cells from LB-treated AO rats 
produced superior amount of peroxide on d2 and d7 rela-
tive to cells from DA rats.
Adherent peritoneal cavity cells from both rat strains 
produced TNF-α (higher in PBS-treated AO than in PBS-
treated DA rats) and IL-10 (higher in all groups of DA than 
in AO rats, Fig. 5B, C). LB injection diminished TNF-α 
release from cells obtained on d7 from AO rats, increased 
it in peritoneal cells obtained on d2 from DA rats, but did 
not affect IL-10 production in any way (Fig. 5B, C).
At the same time, injection of LB did not affect NO 
release from AO rats’ peritoneal cells, but significantly 
decreased release of urea in cells isolated on d7 (Fig. 5D, 
E), which resulted in increased ratio of NO to urea (NO/
Urea) in this rat strain (Fig. 5F). In DA rats, injection of 
LB augmented NO release from both d2 and d7 cells and 
decreased urea release on d7, which led to augmented 
NO/urea ratio on d2 and d7 following LB injection 
(Fig. 5D, E). Even though cells from LB-treated rats of 
DA strain produced superior amounts of NO compared to 
AO rats on d2, cells from all treatment groups of DA rats 
released higher amount of urea than the cells from AO 
rats (Fig. 5D, E). Consequently, NO/urea ratio was higher 
in d2 and d7 cells from AO than in respective groups of 
DA rats (Fig. 5F).
The Effect of In Vitro Stimulation with Selected 
Microbiota on Hydrogen Peroxide  (H2O2), 
Nitric Oxide, and Urea Release from Adherent 
Peritoneal Cavity Cells Following 
Intraperitoneal Injection of LB
In vitro treatment with E. Coli or Enterococcus spp. 
significantly increased  H2O2 release only in cells from PBS-
treated but not by those from LB- treated AO rats (Fig. 6A). 
Actually, both bacteria suppressed  H2O2 release from peri-
toneal cavity cells isolated from AO rats on d7 following 
LB injection (Fig. 6A). In DA rats E. Coli and Enterococcus 
spp. augmented  H2O2 release by cells from PBS-treated and 
LB-injected rats obtained on d2 (Fig. 6A). However, in vitro 
treatment with Enterococcus spp. decreased  H2O2 release 
from LB-treated DA rats’ cells obtained on d7 (Fig. 6A).
In vitro treatment with LPS increased NO release 
by peritoneal cells from PBS-treated and LB-treated AO 
rats on d2, but stimulated release of urea in cells from all 
Fig. 3  Representative dot plot showing gating strategy for discrimina-
tion of MHCII vs. CD163 (A) and the proportion of  CD163+MHCII− 
(upper left),  CD163+MHCII+ (lower left),  CD163−MHCIIlow (upper 
right), and  CD163−MHCIIhi (lower right) cells (B) in rats of Albino 
Oxford (AO) and Dark Agouti (DA) rat strains following intraperi-
toneal treatment with phosphate buffer saline (PBS), or two (d2) and 
seven (d7) days following intraperitoneal treatment with Lactobacillus 
rhamnosus (LB). The number of rats was 3–6 per group. Statistically 
significant differences: #p < 0.05 and ##p < 0.01 vs. PBS; ap < 0.05, and 
cp < 0.001 vs. AO rats.
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groups of AO rats (Fig. 6B, C). This eventually resulted 
in NO/urea ratio comparable to that in RPMI-treated cells 
(Fig. 6D). On the contrary, treatment with E.coli stimu-
lated NO in peritoneal cells from AO rats of all experi-
mental groups, but exerted more complex effect on urea, 
as it diminished urea in cells from PBS-treated AO rats 
and had no effect on cells obtained on d2 and d7. In vitro 
treatment with Enterococcus spp. increased NO release 
in cells from LB-treated AO rats on d2, and slightly sup-
pressed urea in cells from PBS-treated and LB-treated 
on d2 (Fig. 6B, C) Finally, both E.coli and Enterococcus 
spp. treatment increased NO/urea ratio in cells from PBS-
treated and LB-treated rats on d2. Increasing effects of 
E.coli and Enterococcus spp. on NO/urea were not seen 
in cells obtained on d7 (Fig. 6D).
In cells from DA rats, in vitro treatment with LPS 
increased NO release in cells obtained from LB-treated 
animals on d2 but increased urea release in cells from 
LB-treated rats on d2 and d7 (Fig. 6B, C). Treatment 
with E.coli increased NO release in cells from all experi-
mental groups of DA rats, but had no effect on urea pro-
duction. However, in vitro treatment with Enterococcus 
spp. increased NO production only in d2 cell, and did not 
affect production of urea in any of the animals (Fig. 6B, 
C). Further analysis showed that only treatment in vitro 
with own E.coli was able to skew production toward NO 
instead of urea in cells from LB-treated DA rats on d2 and 
d7, while treatment with Enterococcus spp. did not affect 
NO/Urea ratio (Fig. 6D).
DISCUSSION
Our study showed that inflammatory reaction 
toward live LB, as well as the ability of LB to affect cell 
responses to microbiota stimulation in vitro, followed rat 
strain-specific pattern. Single intraperitoneal injection of 
LB provoked increase in peritoneal cell yield two days 
later in both rat strains, with characteristic decrease in 
the proportion of resident  CD163+ macrophages. This is 
in line with macrophage dissappearance reaction (MDR), 
representing the first response to inflammatory insult in 
serous cavities [44] in which resident peritoneal cav-
ity macrophages robustly up-regulate the expression of 
adhesive molecules and coagulation pathway to form 
fibrin clots in omentum [45], becoming practically irre-
trievable from lavage. Microorganisms that access the 
peritoneal cavity through the digestive tract are in this 
way efficiently trapped in clots, even before they have a 
chance to be phagocytosed [45]. Contingent with inflam-
matory cascade reaction [46] an influx of inflammatory 
 CD43+HIS48+ monocytes and a rise in the proportion 
of inflammatory  CD163−MHCIIlow macrophages were 
also observed on d2 in both rat strains. As Ki67 is a 
good indicator of proliferative potential and a measure 
of  G1 in macrophages [47], a diminished proportion of 
 CD68+Ki67+ macrophages on d2 relative to control rats 
of both strains suggests that a low proportion of prolif-
erating macrophages is sufficient to rebuild peritoneal 
cellular milieu in days following MDR [48]. The greater 
proliferative capacity in rats of AO rat strain both basally 
and following LB injection (d2 and d7), opposed to influx 
of inflammatory  CD163−MHChi macrophages/dendritic 
cells on d2 only in rats of DA strain, confirms that the bal-
ance of proliferative expansion of resident macrophages 
versus recruitment of monocyte during infection may 
vary between inbred animal strains [49].
In accordance with lesser contribution of  CD163+ 
cells to  MHCII+ cell pool during inflammation [50], 
the ratio of  CD163+ macrophages within  MHCII+ 
cells, which was initially higher in AO than in DA rats, 
decreased on d2 in both rat strains (from ~ 68 to ~ 27% 
for AO, and from ~ 38 to ~ 10% for DA rats) and returned 
to basal levels at d7. The prevalence of resident  CD163+ 
mature macrophages in the peritoneal cavity of AO 
rats is in contrast to higher proportion of non-resident 
macrophages, especially those expressing MHCII, both 
basally and during inflammation, in rats of DA rat strain. 
Even though expression of CD163 is increased by anti-
inflammatory cytokines IL-4/13 and IL-10 [51] and 
associated with immunomodulatory/tissue remodeling 
M2 profile [52], CD163-expressing macrophages also 
express M1 monocyte/macrophage marker CCR7 [53] 
that is up-regulated by pro-inflammatory cytokines IFNγ 
and GM-CSF [51]. Thus, the ratio of CCR7/CD163 gene 
expression in single cell or within cell population may 
indicate the prevalence of M1 or M2 response [54]. The 
Fig. 4  Representative dot plots showing the CD43 vs. HIS48 
immunofluorescence profile (A) and backgating to Forward Scatter 
(FSC, general size) vs. Side Scatter (SSC, granularity) profile show-
ing discrimination between  SSClow (G1, left) and  SSChi (G2, right) 
 HIS48+CD43+ cells (A). The proportion of  SSClowHIS48+CD43+ 
(left) and  SSChiHIS48+CD43+ (right) cells (B) in rats of Albino 
Oxford (AO) and Dark Agouti (DA) rat strains following intraperi-
toneal treatment with phosphate buffer saline (PBS), or two (d2) and 
seven (d7) days following intraperitoneal treatment with Lactobacillus 
rhamnosus (LB). The number of rats was 3–6 per group. Statistically 
significant differences: ##p < 0.01 vs. PBS; ap < 0.05, vs. AO rats.
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Fig. 5  The release of hydrogen peroxide  (H2O2) (A), TNF-α (B), IL-10 (C), Nitric oxide (NO) (D), and Urea (E), and NO/Urea ratio (F), by adher-
ent peritoneal cells from rats of Albino Oxford (AO) and Dark Agouti (DA) rat strains following intraperitoneal treatment with phosphate buffer 
saline (PBS), or two (d2) and seven (d7) days following intraperitoneal treatment with Lactobacillus rhamnosus (LB). The number of rats was 3–6 
per group. Statistically significant differences: #p < 0.05 and ##p < 0.01 vs. PBS; ap < 0.05, bp < 0.01, and. cp < 0.001 vs. AO rats.
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greater proportion of CCR7-expressing  CD163+ mac-
rophages in DA than in AO rats following PBS treatment 
and on d7 and, more importantly, the greater proportion 
of CCR7-expressing than CCR7-negative  CD163+ mac-
rophages within  CD163+ macrophage pool in DA rats, 
additionally supports more intense priming of DA rat 
cells by local peritoneal millieu [6], both under basal con-
ditions and during resolution following LB injection. The 
presence of CCR7 molecule on all  CD163+ macrophages 
on d2 following LB in rats of both rat strains creates an 
inflammatory milieu that is a prerequisite for later pro‐
fibrotic environment and development of fibrosis during 
the chronic phase of inflammation [55]. It remains to be 
elucidated whether generally superior CCR7 expression 
in peritoneal cellular millieu of DA rats compared to rats 
of AO rat strain may explain generally higher production 
of wound-healing urea in macrophages from DA rats.
Peritoneal cavity cell production of cytotoxic mol-
ecules and cytokines also differed between rat strains and 
were differently affected by i.p. LB treatment. Interest-
ingly, although high macrophage production of TNF-α 
was associated with susceptibility to autoimmune dis-
eases in rats of DA strain [56], peritoneal cavity cells from 
autoimmune-resistant AO strain produced higher levels 
of TNF-α. Nevertheless, in the presence of pro-fibrotic/
anti-inflammatory TGF-β, highly produced by cells of 
AO rats [57], TNF-α can induce peripheral  Foxp3+ T 
regulatory cells that may yield the most suppressive T 
cell phenotype that dampen the development of autoim-
munity [58]. Besides, higher levels of  H2O2 produced by 
cells of AO rats create an oxidative environment in the 
vicinity of immunological synapse, making it less favour-
able for development of autoreactive T cells in rats of 
this strain [59]. Conversely, significantly higher ability 
to produce IL-10 that was previously reported in central 
nervous system-infiltrating immune cells, cervical lymph 
node cells, and in peritoneal cavity inflammatory cells of 
DA compared to AO rats [16, 57, 60] was found to be 
important for susceptibility to Trichinella spiralis infection 
and for the recovery from EAE in DA rat strain [57, 60]. 
IL-10 prevents intraperitoneal recruitment of peripheral 
monocytes, but has no effect on recruitment of  MHCIIhi 
dendritic/macrophage‐like cells during inflammation [61], 
which may explain modest increase in the proportion of 
 CD163−MHCIIlow monocytes and steep rise in the propor-
tion of  CD163−MHCIIhi inflammatory macrophages/den-
dritic cells on d2 in DA rats. Dendritic cells, in addition to 
high levels of superoxide oxidase which detoxifies super-
oxide radicals from monocyte/macrophage activation, also 
significantly express peroxiredoxin enzymes which are 
involved in the efficient removal of  H2O2 [62]. Although 
lactobacilli are among the most potent inducers of reac-
tive oxygen species both in vitro and in vivo [63], changes 
in the composition of peritoneal cells in DA rats on d2, 
i.e. influx of dendritic-like cells, may have contributed to 
diminished  H2O2 production in this rat strain.
Previous reports show that direct stimulation with 
L. rhamnosus GG augments the TNF-α and IL-10 expres-
sion in monocyte-derived macrophages [64], whereas in 
our study, i.p. treatment with LB also increased TNF-α 
and NO release by cells obtained on d2 only in DA rats, 
but did not affect IL-10 or urea release in either rat strain 
on d2. It may be corroborated that LB, like some bacte-
ria [65], induces migration and differentiation of  CCR2+ 
monocytes toward inflammatory TNF-α/iNOS-producing 
peritoneal dendritic cells. Inflammatory  CCR2hi mono-
cytes that are selectively recruited to the peritoneum dur-
ing peritonitis also express CCR7 [66]. Hence, it would 
be interesting to explore if greater proportion of  CCR7+ 
cells and higher expression level of CCR7 molecules in 
cells of DA rats [6] may facilitate migration and putative 
differentiation of inflammatory monocytes to inflamma-
tory dendritic cells in this rat strain.
In further course of experiment, it was noticed that 
the peritoneal cell yield and the ratio of  CD163+ cells in 
both rat strains on d7 after LB returned to values compa-
rable to PBS-treated rats. However, cells obtained on d7 
were functionally different compared to those from PBS-
treated rats. Cells obtained on d7 retained some of the 
inflammatory features observed in cells on d2—increased 
capacity to release NO (DA) and  H2O2 (AO), but these 
cells in AO rats produced less TNF-α, and those from 
DA rats released more  H2O2, whereas cells from both 
strains on d7 had lower arginase activity relative to cells 
from PBS-treated animals. Hydrolysis of L-arginine by 
arginase to urea and L-ornithine limits availability of 
arginine for iNOS-mediated production of anti- 
proliferative and cytotoxic NO [67], and several bacteria and 
parasites increase host arginase activity to circumvent 
NO-mediated killing [68]. Decrease in arginase activity 
favours NO and, together with enhanced  H2O2 release by 
d7 cells, boosts antimicrobial potency of these cells. Cells 
from AO rats on d7 have greater antimictobial potency 
than those from DA rats. Thus, even though cell phe- 
notype on d7 suggest cesation of LB-induced inflamma-
tory response (i.e., resident  CD163+ cells repopulated 
the peritoneal cavity, in AO rats being more represented 
than in PBS-treated controls, and the proportion of 
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 CD163−MHCIIlow inflammatory and  CD163−MHCIIhi 
macrophages/dendritic cells in DA rats returned to basal 
level as in PBS-treated controls), the origin of these 
cells, i.e., proliferation or recruitment following MDR, 
and their experience of adhesion, extravasation, prolif-
eration, and stimulation, is different to that of cells pre-
inflammation. Previous reports showing that beneficial 
effect(s) of probiotic consumption may be mimicked by 
its single i.p. injection [28] must be interpeted cautiosly, 
as the flow of the events includes alterations in perito-
neal cavity cell composition and activity that change over 
time. Moreover, these changes may vary between hosts, 
suggesting that immunomodulatory properties of probiot-
ics depend on recipient’s immune response. In addition 
to numerous data showing that, for example, variability 
in the effect of probiotic supplementation is a result of 
inter-individual differences in probiotic colonization [31], 
our results suggest that this variability may be also due 
to differences in host innate immunity, which corrobo-
rate the necessity of personalized use of probiotics and 
patient-based immunotherapy.
Finally, in further course of the study, we treated 
adherent peritoneal macrophages [38] isolated from PBS- 
or LB-treated AO and DA rats with autologous faecal 
formalin-killed Gram ( −) and Gram ( +) bacteria, and 
followed the changes in NO and  H2O2 release, and argi-
nase activity. Signature components of the cell wall of 
Gram ( −) and Gram ( +) bacteria, LPS, and lipoteichoic 
acid (LTA), respectively, may both induce oxidative 
stress and NO production [69, 70]. LPS, but not LTA, 
was shown to stimulate arginase activity [71, 72]. Here, 
in vitro treatment with autologous E.coli increased NO 
but suppressed (AO rats) or did not influence (DA rats) 
urea release, whereas commercially available LPS (from 
E.coli O111:B4) mostly increased both NO and urea. This 
points to additional LPS-independent mechanism(s) in 
the effect of E.coli, as previously suggested [73]. Alterna-
tively, behaviour of bacterium-free LPS may be different 
from bacterium-bound LPS [74]. In AO rats, E. coli- and 
Enterococcus spp.-induced increase in  H2O2 release (on 
d2 and d7) and cell polarization toward inflammatory 
M1 pattern (i.e., increase in NO/urea ratio on d7) were 
abrogated by previous i.p. treatment with LB. Quite the 
contrary, in DA rats, i.p. treatment with LB on d2 potenti-
ated release of NO induced by both bacteria resulting in 
inflammatory M1 skewing by E. coli toward higher NO/
urea ratio, but prevented increase in  H2O2 release induced 
by E. coli and Enterococcus spp. in vitro in cells from d7. 
Other researchers reported that preincubation of epithe-
lial cells with L. rhamnosus diminished E. coli-induced 
modulation of genes involved in inflammation [75]. Alto-
gether, this implies that beneficial probiotic action(s) may 
include reconditioning of the pathogen sensing by the 
immune system [76].
Our results suggest that injection of LB had greater 
potential in AO than that in DA rats to prevent the func-
tional changes induced by in vitro stimulation of perito-
neal cavity cells with commensal microflora. Lactobacilli 
were shown to be potent immunomodulators in various 
models of inflammation and tumour, in vivo as well as 
in vitro [77]. However, animal substrain differences in the 
composition of gut microbiota, resulting from the propa-
gation by different vendors, influence both the severity of 
tumour progression and the efficacy of anti-tumor therapy 
[78], which underlines the importance of the host genetics 
for the outcome of probiotic stimulation.
Host genetics is important for the rat strain-specific 
cell activation pattern during LB-induced inflammation, 
as well as for the outcome of the in vitro stimulation with 
E. coli and Enterococcus spp. [79]. Direct stimulation of 
peritoneal cavity cells by LB produces changes in cell 
phenotype that alter their response to stimulation with 
fecal bacteria. This may have either protective or deleteri-
ous effect on development of conditions associated with 
dysbiosis, and is strongly affected by animal strain.
CONCLUSION
Our results disclosed clear rat strain differences 
in (a) the peritoneal cavity cell response to stimula-
tion with LB and (b) the ability of LB to affect cell 
responses to microbiota stimulation in vitro. In gen-
eral, the final outcome of the peritoneal cell stimula-
tion with autologous microbiota in vitro is mainly deter-
mined by rat strain-dependent profile of cell response 
to intraperitoneal stimulation with LB. In addition to 
the well-known importance of the probiotic strain for 
Fig. 6  The effect of in vitro stimulation with E.coli or Enterococcus 
spp. on release of hydrogen peroxide  (H2O2) (A), nitric oxide (NO) 
(B), and urea (C), and on NO/Urea ratio (D), by adherent peritoneal 
cells isolated from rats of Albino Oxford (AO) and Dark Agouti (DA) 
rat strains following intraperitoneal treatment with phosphate buffer 
saline (PBS), or two (d2) and seven (d7) days following intraperito-
neal treatment with Lactobacillus rhamnosus (LB). The number of 
rats was 3–6 per group. Statistically significant differences: *p < 0.05 
and **p < 0.01 vs PMA (or RPMI); #p < 0.05 and ##p < 0.01 vs. PBS; 
ap < 0.05, bp < 0.01, and cp < 0.001 vs. AO rats.
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inducing strain-specific immunomodulatory properties, 
it must be underlined that the ability of particular pro-
biotic bacteria to alter the activity of immune cells and 
their response to commensals or pathogens is shaped 
by the interactions of host genetics and (inflammatory) 
cascade of the events produced following probiotic 
administration. These results may add to growing field 
of investigations that points to the importance of tailor-
ing probiotics for personalized use.
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